Insider Selling: Oscar Health (NYSE:OSCR) Insider Sells 9,859 Shares of Stock

by · The Cerbat Gem

Oscar Health, Inc. (NYSE:OSCR – Get Free Report) insider Adam Mcananey sold 9,859 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares of the company’s stock, valued at approximately $4,785,026.24. This represents a 4.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

Shares of OSCR traded up $3.04 during trading hours on Thursday, reaching $23.54. 10,532,228 shares of the company’s stock traded hands, compared to its average volume of 7,845,401. The stock has a market cap of $7.10 billion, a PE ratio of -39.90, a price-to-earnings-growth ratio of 1.48 and a beta of 2.37. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The firm’s 50 day simple moving average is $17.92 and its 200-day simple moving average is $15.93. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $25.58.

Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The company’s revenue for the quarter was up 52.6% on a year-over-year basis. During the same quarter last year, the company posted $0.92 EPS. Equities analysts expect that Oscar Health, Inc. will post 0.47 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on OSCR. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Tuesday, April 21st. Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and boosted their target price for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. Robert W. Baird boosted their target price on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. Finally, Wall Street Zen upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Saturday, May 9th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $20.22.

Read Our Latest Research Report on Oscar Health

Institutional Trading of Oscar Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. OneDigital Investment Advisors LLC grew its stake in Oscar Health by 0.6% in the third quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock worth $2,617,000 after purchasing an additional 779 shares during the period. Focus Partners Wealth lifted its position in Oscar Health by 1.4% during the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after buying an additional 824 shares during the period. Equitable Holdings Inc. lifted its position in Oscar Health by 7.0% during the fourth quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after buying an additional 850 shares during the period. Captrust Financial Advisors lifted its position in Oscar Health by 2.0% during the fourth quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock valued at $657,000 after buying an additional 895 shares during the period. Finally, O Shaughnessy Asset Management LLC lifted its position in Oscar Health by 5.6% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock valued at $255,000 after buying an additional 938 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

Featured Stories